ARTICLES BY THIS AUTHOR
- 2/4/2020
Augia Pharma gets FDA nod for generic Rheumatrex
Methotrexate tablets have a market value of roughly $98 million for the 12 months ended December 2019, according to IQVIA. - 2/4/2020
McKesson sees revenue gains in Q3
McKesson's pharmaceutical and specialty solutions segment saw Q3 2020 revenue up 6% over Q3 2019, totaling $46.9 billion. - 2/4/2020
NACDS' Anderson addresses coronavirus and pharmacists' readiness in op-ed
Pharmacists are committed to responding to public health emergencies such as the coronavirus, and patients' needs every day, NACDS' Steve Anderson writes in an op-ed on Medium. - 2/3/2020
Allergan launches Ubrelvy
Allergan is offering Ubrelvy for the acute treatment of migraine with or without aura in adults. - 2/3/2020
Seqirus gets FDA nod for Audenz
The FDA has approved the first adjuvanted, cell-based Pandemic Influenza A (H5N1) vaccine. - 2/3/2020
Global sales of branded generics are expected to grow by 8%
Antihypertensives are expected to be the best-selling global branded generics category. - 2/3/2020
CVS Health slims down its board
CVS Health’s board will transition from 16 to 13 directors, with two longtime directors retiring and the former CEO of Aetna departing after the company's annual meeting. - 1/31/2020
FDA clear 2 generics from Alembic
Clobetasol propionate cream and azithromycin tablets had a market value of $57 million, and $129 million respectively. - 1/31/2020
Coborn's centralizes prescription fulfillment via McKesson HVS
Coborn's and McKesson HVS partnered to develop and execute a central fill strategy that meets Coborn's current business needs. - 1/30/2020
HTL-STREFA's Prevent DropSafe Safety Pen Needles awarded McKesson's 2019 New Product of the Year
The Prevent DropSafe Safety Pen Needle, which utilizes a thin 31-gauge needle, is McKesson's 2019 product of the year.